CH Argenteuil
- Address
- 69, rue du Lieutenant-Colonel Prudhon,, 95100 Argenteuil, France
CH Argenteuil - Multicenter Clinical Research
CH Argenteuil participates in advanced clinical research across multiple therapeutic domains, contributing to pivotal multicenter studies that address complex medical conditions. The center demonstrates particular expertise in critical care infectious diseases, oncology, and hematologic malignancies, conducting randomized controlled trials that evaluate novel therapeutic strategies and treatment optimization.
- Intensive care unit infectious disease management, including fungal peritonitis and intra-abdominal infections
- Advanced lung cancer immunotherapy trials evaluating checkpoint inhibitor combinations
- Hematologic oncology research focused on relapsed and refractory multiple myeloma treatment protocols
The research portfolio includes investigations of antifungal therapy with caspofungin for ICU patients with yeast infections, comparative studies of nivolumab and ipilimumab immunotherapy regimens in stage IV non-small cell lung cancer, and innovative approaches to dexamethasone-based salvage therapy for advanced multiple myeloma. These studies reflect the center's commitment to evidence-based medicine and improving outcomes for patients with life-threatening conditions through rigorous clinical trial methodologies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CH Argenteuil
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Dexamethasone as Initial Therapy in Advanced Relapsed/Refractory Multiple Myeloma: A Randomized, Open-Label, Non-Inferiority Trial | Assistance Publique Hopitaux De Paris | Phase III | Recruiting | Dec 2024 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Caspofungin | 1 | Unknown | 2020-01-06 | 2020-01-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.